Cerenome, Inc. (CNSY) vs CytoMed Therapeutics Limited (GDTC)

A side-by-side comparison of Cerenome, Inc. and CytoMed Therapeutics Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CNSY

Cerenome, Inc.

$11M

$1.61HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT

GDTC

CytoMed Therapeutics Limited

$11M

$0.89HealthcareDelayed quote: Oct 6, 2026, 2:53 PM EDT

Total return — CNSY vs GDTC

growth of $100 · dividends reinvested · last 1y

CNSY -61.5% (-61.5%/yr)GDTC +4.1% (+4.1%/yr)GDTC compounded faster over this window

CNSY GDTC

Metrics side by side

Total return (annualized)

Metric	CNSY	GDTC
Total return (1Y)	N/A	-49.59%
Total return CAGR (3Y)	N/A	-34.77%

GDTC is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CNSY analysis Full GDTC analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.